S&P 500

5.270,29

-0,25%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Pulmatrix Inc (PULM)
Pulmatrix Inc (PULM) Notícias

PULM

Pulmatrix (PULM)

Pulmatrix Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:PULM

1 2 3 4 5 6 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
31/05/2024	01:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:PULM	Pulmatrix Inc
29/05/2024	09:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PULM	Pulmatrix Inc
17/05/2024	17:06	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PULM	Pulmatrix Inc
10/05/2024	10:20	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PULM	Pulmatrix Inc
12/05/2023	10:21	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PULM	Pulmatrix Inc
12/05/2023	10:06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PULM	Pulmatrix Inc
30/01/2023	18:07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:PULM	Pulmatrix Inc
16/05/2022	07:28	TipRanks	H.C. Wainwright Thinks Pulmatrix’s Stock is Going to Recover	NASDAQ:PULM	Pulmatrix Inc
29/04/2022	17:08	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:PULM	Pulmatrix Inc
19/04/2022	17:28	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:PULM	Pulmatrix Inc
29/03/2022	18:23	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:PULM	Pulmatrix Inc
29/03/2022	10:21	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:PULM	Pulmatrix Inc
14/02/2022	17:29	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:PULM	Pulmatrix Inc
01/02/2022	11:10	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:PULM	Pulmatrix Inc
01/02/2022	11:00	PR Newswire (US)	Pulmatrix Issues Letter to Stockholders	NASDAQ:PULM	Pulmatrix Inc
17/12/2021	08:14	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:PULM	Pulmatrix Inc
27/07/2021	11:00	PR Newswire (US)	Pulmatrix appoints Director Anand Varadan	NASDAQ:PULM	Pulmatrix Inc
13/04/2021	17:09	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:PULM	Pulmatrix Inc
13/04/2021	09:15	TipRanks	Pulmatrix Will Regain Full Rights To PUR1800 After Termination Of Licensing Agreement; Shares Fall 16%	NASDAQ:PULM	Pulmatrix Inc
26/03/2021	17:01	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:PULM	Pulmatrix Inc
24/02/2021	12:23	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PULM	Pulmatrix Inc
23/02/2021	18:21	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:PULM	Pulmatrix Inc
14/08/2020	07:08	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:PULM	Pulmatrix Inc
07/08/2020	17:31	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:PULM	Pulmatrix Inc
06/07/2020	07:31	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:PULM	Pulmatrix Inc
25/06/2020	17:16	Edgar (US Regulatory)	Securities Registration Statement (s-1)	NASDAQ:PULM	Pulmatrix Inc
23/04/2020	15:15	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:PULM	Pulmatrix Inc
18/09/2019	10:30	PR Newswire (US)	Pulmatrix and Cipla Announce First Patient Dosed in Phase 2 Trial Evaluating Pulmazole for Treatment of Allergic Bronchopulmo...	NASDAQ:PULM	Pulmatrix Inc
19/08/2019	10:25	PR Newswire (US)	Pulmatrix Receives US Patent Covering iSPERSE™ Formulations for Pulmazole Program	NASDAQ:PULM	Pulmatrix Inc
05/08/2019	10:00	PR Newswire (US)	Pulmatrix Reports Q2 2019 Results	NASDAQ:PULM	Pulmatrix Inc